Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A 5-min RNA preparation method for COVID-19 detection with RT-qPCR

Alim Ladha, Julia Joung, Omar O. Abudayyeh, Jonathan S. Gootenberg, Feng Zhang
doi: https://doi.org/10.1101/2020.05.07.20055947
Alim Ladha
1Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Joung
1Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Omar O. Abudayyeh
2McGovern Institute for Brain Research at MIT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan S. Gootenberg
2McGovern Institute for Brain Research at MIT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Feng Zhang
1Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
2McGovern Institute for Brain Research at MIT
3Howard Hughes Medical Institute, Cambridge, MA 02139, USA
4Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA
5Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: zhang@broadinstitute.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

RNA extraction has become a bottleneck for detection of COVID-19, in part because of reagent shortages. We present here a rapid protocol that circumvents the need for RNA extraction that is compatible with RT-qPCR-based detection methods.

A. Overview

The novel coronavirus SARS-CoV-2 causes COVID-19 and has resulted in an international public health emergency, spreading to over 180 countries and infecting more than 350,000 individuals. Testing for the presence of the virus is of utmost importance to both reduce the basic reproductive rate of the virus (R0) and inform best clinical practices for affected patients. However, understanding the full extent of the virus outbreak has remained challenging due to bottlenecks in the diagnosis of infection.

One of the major bottlenecks for COVID-19 diagnosis is the limited availability of RNA extraction kits for preparing virus RNA from patient samples and the low-throughput nature of the extraction procedure. Here, we describe an one-step column-free RNA preparation method that can be carried out in 5 minutes. The reaction can be used directly with the CDC COVID-19 RT-qPCR testing protocol, thus increasing throughput and alleviating supply chain issues.

B. Materials and Reagents

  • - Quick Extract™ DNA Extraction Solution (QE09050), Lucigen. Once thawed, aliquot and store at −20C to avoid >3 freeze-thaw cycles.

C. Protocol

  1. Dilute nasopharyngeal swab stored in Viral Transport Medium or Human Specimen Control (HSC) 1:1 with Quick Extract™ DNA Extraction Solution. For example, in a fresh PCR tube, mix 20 µl of swab sample with 20 µl of Quick Extract.

  2. Incubate swab and Quick Extract mix at 95°C for 5 minutes. Allow reaction to cool on ice before proceeding.

  3. Use reaction from step (2) for qRT-PCR. Use an amount from step (2) that corresponds to 10 % of the total qRT-PCR reaction volume. For example, for a reaction with total volume of 50 µl, use 5 µl of the reaction from step (2).

D. Assay Development and Preliminary Validation

We evaluated a number of buffer compositions to identify one that achieved efficient lysis of enveloped virus while preserving the activity of the CDC recommended RT-qPCR reaction (TaqPath™ 1-Step RT-qPCR Master Mix). Of all of the buffers tested, Quick Extract™ DNA Extraction Solution provided results that were comparable to standard RNA extraction kits.

To confirm that the presence of QE does not interfere with RT-qPCR activity, we compared RT-qPCR reactions using synthetic SARS-CoV-2 gene fragment (Twist Synthetic SARS-CoV-2 RNA Control 1, SKU:102019) dissolved in either ddH2O or in a 50:50 ddH2O:Quick Extract mixture. We set up each RT-qPCR reaction with a total volume of 10 µl (1 µl of RNA sample, 0.5 µl of CDC probe N1, 2.5 µl of TaqPath RT-qPCR master mix, and 6 µl of ddH2O). From these reactions, we found that Quick Extract at a final concentration of 5 % did not negatively affect the RT-qPCR reaction (Figure 1A; 2 technical replicates).

Figure 1.
  • Download figure
  • Open in new tab
Figure 1.

A) RT-qPCR of synthetic SARS-CoV-2 RNA control (Twist Synthetic SARS-CoV-2 RNA Control 1, SKU:102019) diluted in water or 50:50 ddH2O:Quick Extract mixture. Final sample volume was 1 µL in a 10 µL reaction. B) RT-qPCR of diluted COVID-19 positive nasopharyngeal swabs treated at 95°C for 5 minutes in Quick Extract or purified using QIAmp Viral RNA Miniprep.

We conducted preliminary validation of the Quick Extract RNA preparation procedure on COVID-19 positive nasopharyngeal swabs and found that RNA samples prepared using Quick Extract supported similarly sensitive detection of coronavirus as QIAmp Viral RNA Miniprep (Qiagen) for all 4 swab samples (Figure 1B; 2 biological replicates). To simulate low viral load, coronavirus positive swabs were diluted 1:10 in pooled nasopharyngeal swabs from 5 healthy donors (Lee Biosolutions, SKU:991-31-NC-5) prior to purification or Quick Extract treatment. For the QIAmp Viral RNA Miniprep conditions, 100 µL of diluted swab sample was used for extraction and was eluted using 100 µL of ddH2O. 1 µL of the elution was used in a 10 µL RT-qPCR reaction. For the Quick Extract conditions, 1 µL of Quick Extract preparation was used for each 10 µL RT-qPCR reaction.

Data Availability

All of the data is presented in the paper.

Ethical Statement

Patient samples were existing biospecimens and de-identified. This work (E-2031, CRISPR-based Diagnostics) was determined to be “not human subjects research” by MIT (as defined by Federal regulation 45 CFR 46 under the following: Exempt Category 4 - Secondary Use Research).

Acknowledgements

We would like to thank Keith Jerome, Alex Greninger, Meei-Li Huang, and Bob Bruneau of the University of Washington for generously providing COVID-19 nasopharyngeal swab samples. We would like to acknowledge support from the McGovern Institute; the Howard Hughes Medical Institute; Open Philanthropy Project; James and Patricia Poitras; and Robert Metcalfe.

View Abstract
Back to top
PreviousNext
Posted May 08, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A 5-min RNA preparation method for COVID-19 detection with RT-qPCR
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A 5-min RNA preparation method for COVID-19 detection with RT-qPCR
Alim Ladha, Julia Joung, Omar O. Abudayyeh, Jonathan S. Gootenberg, Feng Zhang
medRxiv 2020.05.07.20055947; doi: https://doi.org/10.1101/2020.05.07.20055947
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
A 5-min RNA preparation method for COVID-19 detection with RT-qPCR
Alim Ladha, Julia Joung, Omar O. Abudayyeh, Jonathan S. Gootenberg, Feng Zhang
medRxiv 2020.05.07.20055947; doi: https://doi.org/10.1101/2020.05.07.20055947

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (62)
  • Allergy and Immunology (144)
  • Anesthesia (47)
  • Cardiovascular Medicine (419)
  • Dentistry and Oral Medicine (72)
  • Dermatology (49)
  • Emergency Medicine (147)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (174)
  • Epidemiology (4906)
  • Forensic Medicine (3)
  • Gastroenterology (185)
  • Genetic and Genomic Medicine (689)
  • Geriatric Medicine (72)
  • Health Economics (193)
  • Health Informatics (636)
  • Health Policy (322)
  • Health Systems and Quality Improvement (209)
  • Hematology (86)
  • HIV/AIDS (157)
  • Infectious Diseases (except HIV/AIDS) (5408)
  • Intensive Care and Critical Care Medicine (333)
  • Medical Education (96)
  • Medical Ethics (24)
  • Nephrology (77)
  • Neurology (692)
  • Nursing (42)
  • Nutrition (115)
  • Obstetrics and Gynecology (128)
  • Occupational and Environmental Health (211)
  • Oncology (447)
  • Ophthalmology (140)
  • Orthopedics (36)
  • Otolaryngology (91)
  • Pain Medicine (37)
  • Palliative Medicine (18)
  • Pathology (131)
  • Pediatrics (201)
  • Pharmacology and Therapeutics (131)
  • Primary Care Research (88)
  • Psychiatry and Clinical Psychology (787)
  • Public and Global Health (1832)
  • Radiology and Imaging (328)
  • Rehabilitation Medicine and Physical Therapy (142)
  • Respiratory Medicine (257)
  • Rheumatology (87)
  • Sexual and Reproductive Health (69)
  • Sports Medicine (63)
  • Surgery (102)
  • Toxicology (23)
  • Transplantation (29)
  • Urology (38)